We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Australia: Off-Patent Meds Face 23 Percent Price Cut in Spring
Australia: Off-Patent Meds Face 23 Percent Price Cut in Spring
January 10, 2012
Australian drugmakers have agreed to a new round of market-based price cuts that will lower the cost of off-patent medicines on average 23 percent, beginning April 1.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor